Editor
At the Bench-Glioblastoma: Immunotherapy for Glioblastoma Has a New and Potentially Powerful Target
April 5, 2018 (Neurology Today)
A protein associated with glioblastoma multiform (GBM) has been identified and in experiments has proven to be a promising...
This ‘genetic switch’ could help to fight cancer
April 27, 2018 (Medical News Today)
T cells, a type of white blood cell, have an innate ability to recognize, attack and kill cancer...
CAR T-Cell Immunotherapy Named Clinical Advance of the Year by ASCO
In January, ASCO published its 13th annual report in Clinical Cancer Advances 2018, and named chimeric antigen receptor (CAR) T-cell immunotherapy as its Advance...
‘Cross-dressing’ cells may improve cancer treatment
January 23, 2018 (Medical News Today)
A group of researchers from Switzerland are now focused on improving ‘dendritic cell vaccines’, which are an important...
The state of cancer: Are we close to a cure?
March 2, 2018 (Medical News Today)
At present, the most common types of treatment for cancer – the leading cause of death – are chemotherapy,...
Immunotherapy for Glioblastoma: On the Sidelines or in the Game?
November 28, 2017 (Discovery Medicine)
Glioblastoma remains a major unmet medical need in the field of oncology. With less than 10% of patients surviving five...
Cancer: Some immune cells found to give tumors a helping hand
December 13, 2017 (Medical News Today)
Lung cancer is the most common cause of cancer-related deaths worldwide. It is the second most common cancer...
‘Synthetic gene circuit’ may improve effectiveness of cancer immunotherapy
October 19, 2017 (Medical News Today)
Immunotherapy, which activates a patient’s own immune system to attack cancer, is still a new approach to treating...
Cancer recurrence may be stopped with immunotherapy
October 17, 2017 (Medical News Today)
Scientists and researchers from the UK have set out to investigate why cancer often returns in patients whose...
Immune Status Tied to Outcomes in Third-Gen CAR T-Cell Therapy
September 6, 2017 (HealthDay News)
In leukemia/lymphoma, after treatment CD19-targeting chimeric antigen receptor T-cell therapy
Outcomes of treatment with third-generation CAR T-cell therapy in CD19-positive...
